AMERICAN BIO MEDICA CORP
RW, 1998-09-28
MEASURING & CONTROLLING DEVICES, NEC
Previous: PACIFIC CAPITAL FUNDS, N-30D, 1998-09-28
Next: AMERICAN BIO MEDICA CORP, S-3, 1998-09-28




                        AMERICAN BIO MEDICA CORPORATION
                               300 Fairview Avenue
                             Hudson, New York 12534
                                  800-227-1243

                                                          
                                                    September 25, 1998


BY EDGAR
- --------

Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549


          Re:  American Bio Medica Corporationn
               Registration Statement on Form SB-2
               (Registration No. 333-16535)
               -----------------------------------

Gentlemen and Ladies:

     In accordance with Rule 477  promulgated  under the Securities Act of 1933,
as amended, American Bio Medica Corporation (the "Company") hereby withdraws the
Registration Statement on Form SB-2 (Registration No. 333-16535) initially filed
with the  Securities  and Exchange  Commission  on May 20, 1998.  The Company is
withdrawing the Registration Statement on Form SB-2 because it intends to file a
registration  statement  on Form S-3  covering  the  conversion  of  Series  "D"
Preferred  Shares and the  exercise  of  Warrants  covered  in the  Registration
Statement  on Form  SB-2.  None of the  Common  Shares  which  were to have been
registered  pursuant  to the  Registration  Statement  on Form  SB-2  have  been
publicly sold.

      If you have any questions with respect to this letter, please call either
Steven I. Gutstein, Esq. at (212) 725-7110 or me at (800) 227-1243.



                                     Sincerely,


                                     AMERICAN BIO MEDICA CORPORATION



                                     By: /s/ Stan Cipkowski
                                         ------------------------
                                         Stan Cipkowski,
                                         Chief Executive Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission